Table I.
Clinical and biochemical characteristics of the participants included in the present study.
| Variable | Group
|
||
|---|---|---|---|
| Control (n=53) | SCAD (n=74) | ACS (n=81) | |
| Age, years (mean ± range) | 64.68±8.18 | 68.99±13.62 | 72.72±12.93 |
| Sex, n=m/f | 34/19 | 47/27 | 42/39 |
| History of hypertension, n (%) | 0 (0) | 58 (78) | 61 (75) |
| History of diabetes, n (%) | 0 (0) | 15 (20) | 37 (46) |
| TC, mmol/l | 4.43±0.47 | 4.16±0.95 | 4.50±0.73 |
| TG, mmol/l | 1.01±0.33 | 1.48±0.97a | 1.66±0.57b |
| HDL-C, mmol/l | 1.39±0.26 | 1.07±0.30b | 0.94±0.16b |
| LDL-C, mmol/l | 2.70±0.58 | 2.74±0.52 | 2.80±0.33 |
| Cardiac troponin I, ng/ml | – | 0.03±0.01 | 6.61±17.31c |
| Cardiac troponin T, ng/ml | – | 0.015±0.03 | 0.758±1.95d |
| Creatine kinase-MB, U/l | – | 10.24±7.44 | 45.57±80.27d |
a
P<0.05 and
b
P<0.001 vs. the control group;
c
P<0.05 and
d
P<0.01 vs. the SCAD group. HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride; SCAD, stable coronary artery disease; ACS, acute coronary syndrome; m, male; f, female.